SAN FRANCISCO – Roche AG left no moss growing under its feet at the 33rd Annual J.P. Morgan Healthcare Conference, disclosing a second large deal a day after paying $1.03 billion for a majority stake in genomics analysis firm Foundation Medicine Inc.